These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8771511)

  • 21. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA; Spósito AC; Mansur AP; Solimene MC; Chamone D; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of hyperlipidemia in cardiac transplant recipients.
    Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
    Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G; Weber JC; Sachs D; Korganow AS; Martin T; Kretz JG; Pasquali JL
    Rev Med Interne; 1992; 13(1):61-3. PubMed ID: 1410877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition to labeling of cholestyramine.
    FDA Drug Bull; 1985 Apr; 15(1):7-8. PubMed ID: 3858190
    [No Abstract]   [Full Text] [Related]  

  • 28. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
    Gumprecht J; Zychma M; Grzeszczak W; Kuźniewicz R; Burak W; Zywiec J; Karasek D; Otulski I; Mosur M
    Med Sci Monit; 2003 Sep; 9(9):CS89-91. PubMed ID: 12960932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
    Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
    Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
    [No Abstract]   [Full Text] [Related]  

  • 30. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

  • 32. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choice of lipid-lowering drugs.
    Med Lett Drugs Ther; 1998 Dec; 40(1042):117-22. PubMed ID: 9884672
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hyperlipidaemias. Current avenues and new horizons.
    Janus ED
    Aust Fam Physician; 1989 Sep; 18(9):1071-4, 1078-83, 1086. PubMed ID: 2590074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy of dyslipidemias].
    Lenzi S
    Minerva Med; 1975 Oct; 66(66):3479-82. PubMed ID: 1178140
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine.
    Martens LL; Rutten FF; Erkelens DW; Ascoop CA
    Am J Med; 1989 Oct; 87(4A):54S-58S. PubMed ID: 2508473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of several lipid-lowering drugs on skin total and esterified cholesterol.
    Jacotot B; Beaumont JL; Beaumont V; Buxtorf JC; Edouard L; Doucet F; Carcone B
    Monogr Atheroscler; 1986; 14():193-7. PubMed ID: 3526124
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs in cardiac transplantation.
    Ballantyne CM
    N Engl J Med; 1996 Feb; 334(6):400-1; author reply 401-2. PubMed ID: 8538719
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.